5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Checkpoint inhibitor-related skin reactions in cancer patients are characterized by unique rash specific immune responses
    Meeting Abstract

    Goleva, E.; Lacouture, M.; Lyubchenko, T.; Gu, S.; Xiao, O.; Kraehenbuehl, L.; Berdyshev, E.; Ketosugbo, K.; Moy, A.; Rotemberg, V.; more...
    Journal of Allergy and Clinical Immunology (2024)

    Fulltext@MSK | Save
  • Node positive non-clear cell renal cell carcinoma: Oncological outcomes and genomic insights
    Meeting Abstract

    Eismann, L.; Zucker, M.; Dawidek, M.; Reese, S.; Posada Calderon, L.; Aulitzky, A.; Stief, C.; Coleman, J.; Kotecha, R.; Carlo, M.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Molecular, immunohistochemical and clinical determinants of urothelial carcinoma of the bladder with nested subtype
    Meeting Abstract

    Koll, F. J.; Basar, M.; Chen, Z.; Tin, A. L.; Alam, S. M.; Tallman, J. E.; Clinton, T. N.; Whiting, K.; Chen, J. F.; Sarungbam, J.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Precision oncology: Current and future platforms for treatment selection
    Review

    Tang, X.; Berger, M. F.; Solit, D. B.
    Trends in Cancer (2024)

    Fulltext@MSK | Save
  • Paclitaxel, ifosfamide, and cisplatin as initial salvage chemotherapy for germ cell tumors: Long-term follow-up and outcomes for favorable- and unfavorable-risk disease
    Journal Article

    Gleeson, J. P.; Knezevic, A.; Bromberg, M.; Patil, S.; Sheinfeld, J.; Carver, B. S.; Bains, M.; Jones, D. R.; Bajorin, D. F.; Bosl, G. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer: Analysis of the phase 3 VISION trial
    Journal Article

    Morris, M. J.; de Bono, J.; Nagarajah, J.; Sartor, O.; Wei, X. X.; Nordquist, L. T.; Koshkin, V. S.; Chi, K. N.; Krause, B. J.; Herrmann, K.; more...
    Cancer (2024)

    Fulltext@MSK | Save
  • The role of signaling pathways mediated by the GPCRs CysLTR1/2 in melanocyte proliferation and senescence
    Review

    Huber, T.; Horioka-Duplix, M.; Chen, Y.; Saca, V. R.; Ceraudo, E.; Chen, Y.; Sakmar, T. P.
    Science Signaling (2024)

    Fulltext@MSK | Save
  • RAD21 promotes oncogenesis and lethal progression of prostate cancer
    Journal Article

    Su, X. A.; Stopsack, K. H.; Schmidt, D. R.; Ma, D.; Li, Z.; Scheet, P. A.; Penney, K. L.; Lotan, T. L.; Abida, W.; DeArment, E. G.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2024)

    Fulltext@MSK | Save
  • (177)Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): A phase 3, randomised, controlled trial
    Journal Article

    Morris, M. J.; Castellano, D.; Herrmann, K.; de Bono, J. S.; Shore, N. D.; Chi, K. N.; Crosby, M.; Piulats, J. M.; FleĢchon, A.; Wei, X. X.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Resource use and care quality differences among Medicare beneficiaries undergoing chemotherapy
    Journal Article

    Kalidindi, Y.; Jung, J.; Feldman, R.; Carlin, C.; Song, G.; Mitchell, A.
    JAMA Network Open (2024)

    Fulltext@MSK | Save